Derry O'sullivan
About Derry O'sullivan
Derry O'Sullivan is a Downstream Manufacturing Senior Specialist at Bristol Myers Squibb in Dublin, Ireland, with extensive experience in project and process engineering across multiple industries.
Company
Derry O’Sullivan is currently employed at Bristol Myers Squibb, one of the leading biopharmaceutical companies globally. He operates out of Dublin, County Dublin, Ireland, and serves in a senior role within the company as a Downstream Manufacturing Senior Specialist.
Title
Derry O’Sullivan holds the position of Downstream Manufacturing Senior Specialist at Bristol Myers Squibb. This role involves significant responsibilities in the downstream portion of biopharmaceutical manufacturing, ensuring the purification and polishing of biologics.
Education and Expertise
Derry O’Sullivan completed his education at two institutions. He earned a Bachelor of Engineering (BE) degree in Mechanical Engineering from University College Dublin from 2002 to 2006. Additionally, he received an L9 Certificate in Biopharmaceutical Science from the Institute of Technology, Sligo, in 2016-2017. His educational background provides a solid foundation in both engineering and biopharmaceutical sciences, allowing him to perform effectively in various technical roles.
Background
Derry O’Sullivan has amassed extensive experience across multiple industries over the years. His career began with roles at CRH and Keltech as Project Engineer and Process Engineer, respectively. He then served for six years as a Coordinator for the Korean Government in Sokcho, Gangwon-do, Korea. Upon returning to Ireland, he joined Bristol Myers Squibb, where he transitioned through roles such as QA Specialist and Downstream Bioprocess Associate before becoming a Downstream Manufacturing Senior Specialist.
Previous Roles at Bristol Myers Squibb
Derry O’Sullivan has held multiple positions at Bristol Myers Squibb, showcasing his expertise and versatility. From 2018 to 2019, he was a QA Specialist, focusing on quality assurance processes. From 2019 to 2021, he served as a Downstream Bioprocess Associate, which involved downstream processing of biopharmaceutical products. These roles have equipped him with a comprehensive understanding of biopharmaceutical manufacturing and quality control.